HEADER HYDROLASE/HYDROLASE INHIBITOR 20-MAY-09 3HIT TITLE CRYSTAL STRUCTURE OF SAPORIN-L1 IN COMPLEX WITH THE DINUCLEOTIDE TITLE 2 INHIBITOR, A TRANSITION STATE ANALOGUE COMPND MOL_ID: 1; COMPND 2 MOLECULE: VACUOLAR SAPORIN; COMPND 3 CHAIN: A, B; COMPND 4 EC: 3.2.2.22; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: SAPONARIA OFFICINALIS; SOURCE 3 ORGANISM_COMMON: COMMON SOAPWORT; SOURCE 4 ORGANISM_TAXID: 3572; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS TRANSITION STATE, RIBOSOME INACTIVATING PROTEINS, RIPS, HYDROLASE, KEYWDS 2 PLANT DEFENSE, PROTEIN SYNTHESIS INHIBITOR, TOXIN, HYDROLASE- KEYWDS 3 HYDROLASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR M.HO,M.B.STURM,S.C.ALMO,V.L.SCHRAMM REVDAT 5 21-FEB-24 3HIT 1 REMARK REVDAT 4 01-NOV-17 3HIT 1 REMARK REVDAT 3 21-APR-10 3HIT 1 SEQRES DBREF REMARK SITE REVDAT 2 15-DEC-09 3HIT 1 JRNL REVDAT 1 08-DEC-09 3HIT 0 JRNL AUTH M.C.HO,M.B.STURM,S.C.ALMO,V.L.SCHRAMM JRNL TITL TRANSITION STATE ANALOGUES IN STRUCTURES OF RICIN AND JRNL TITL 2 SAPORIN RIBOSOME-INACTIVATING PROTEINS. JRNL REF PROC.NATL.ACAD.SCI.USA V. 106 20276 2009 JRNL REFN ISSN 0027-8424 JRNL PMID 19920175 JRNL DOI 10.1073/PNAS.0911606106 REMARK 2 REMARK 2 RESOLUTION. 2.29 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.4.0069 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.29 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 51.85 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 97.8 REMARK 3 NUMBER OF REFLECTIONS : 21016 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.175 REMARK 3 R VALUE (WORKING SET) : 0.172 REMARK 3 FREE R VALUE : 0.229 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 1137 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.29 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.35 REMARK 3 REFLECTION IN BIN (WORKING SET) : 1479 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 94.25 REMARK 3 BIN R VALUE (WORKING SET) : 0.1630 REMARK 3 BIN FREE R VALUE SET COUNT : 79 REMARK 3 BIN FREE R VALUE : 0.2680 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4030 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 120 REMARK 3 SOLVENT ATOMS : 327 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 18.83 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 1.25000 REMARK 3 B22 (A**2) : -0.33000 REMARK 3 B33 (A**2) : -1.45000 REMARK 3 B12 (A**2) : 0.27000 REMARK 3 B13 (A**2) : 0.08000 REMARK 3 B23 (A**2) : 0.96000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.486 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.248 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.161 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 6.547 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.943 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.901 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 4234 ; 0.011 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 5768 ; 1.357 ; 1.995 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 512 ; 5.652 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 190 ;40.345 ;25.053 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 700 ;14.321 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 22 ;19.417 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 660 ; 0.082 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 3146 ; 0.004 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 2554 ; 0.507 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 4134 ; 0.969 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1680 ; 1.630 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 1634 ; 2.692 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 3HIT COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 27-MAY-09. REMARK 100 THE DEPOSITION ID IS D_1000053184. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 05-NOV-08 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 5.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 24-ID-C REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.979 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO, HKL-2000 REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 22181 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.290 REMARK 200 RESOLUTION RANGE LOW (A) : 51.850 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.2 REMARK 200 DATA REDUNDANCY : 3.200 REMARK 200 R MERGE (I) : 0.05600 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 14.6360 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.29 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.38 REMARK 200 COMPLETENESS FOR SHELL (%) : 97.7 REMARK 200 DATA REDUNDANCY IN SHELL : 3.30 REMARK 200 R MERGE FOR SHELL (I) : 0.10700 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 45.85 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.27 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 20% PEG2000MME, 0.1M SODIUM ACETATE, REMARK 280 0.4M POTASSIUM THIOCYANATE, PH 5.5, VAPOR DIFFUSION, SITTING REMARK 280 DROP, TEMPERATURE 291K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ASN A 258 REMARK 465 ASN A 259 REMARK 465 ASN B 258 REMARK 465 ASN B 259 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 LEU B 211 CA - CB - CG ANGL. DEV. = 14.4 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 71 10.84 -141.15 REMARK 500 GLU A 194 -123.37 59.72 REMARK 500 ASN B 71 12.23 -145.57 REMARK 500 LYS B 84 27.57 49.16 REMARK 500 VAL B 172 -64.70 -102.45 REMARK 500 GLU B 194 -139.08 58.10 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE DYN A 258 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE DYN B 258 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 3HIO RELATED DB: PDB REMARK 900 RELATED ID: 3HIQ RELATED DB: PDB REMARK 900 RELATED ID: 3HIS RELATED DB: PDB REMARK 900 RELATED ID: 3HIV RELATED DB: PDB REMARK 900 RELATED ID: 3HIW RELATED DB: PDB DBREF 3HIT A 1 259 UNP Q2QEH4 Q2QEH4_SAPOF 22 280 DBREF 3HIT B 1 259 UNP Q2QEH4 Q2QEH4_SAPOF 22 280 SEQRES 1 A 259 VAL ILE ILE TYR GLU LEU ASN LEU GLN GLY THR THR LYS SEQRES 2 A 259 ALA GLN TYR SER THR PHE LEU LYS GLN LEU ARG ASP ASP SEQRES 3 A 259 ILE LYS ASP PRO ASN LEU HIS TYR GLY GLY THR ASN LEU SEQRES 4 A 259 PRO VAL ILE LYS ARG PRO VAL GLY PRO PRO LYS PHE LEU SEQRES 5 A 259 ARG VAL ASN LEU LYS ALA SER THR GLY THR VAL SER LEU SEQRES 6 A 259 ALA VAL GLN ARG SER ASN LEU TYR VAL ALA ALA TYR LEU SEQRES 7 A 259 ALA LYS ASN ASN ASN LYS GLN PHE ARG ALA TYR TYR PHE SEQRES 8 A 259 LYS GLY PHE GLN ILE THR THR ASN GLN LEU ASN ASN LEU SEQRES 9 A 259 PHE PRO GLU ALA THR GLY VAL SER ASN GLN GLN GLU LEU SEQRES 10 A 259 GLY TYR GLY GLU SER TYR PRO GLN ILE GLN ASN ALA ALA SEQRES 11 A 259 GLY VAL THR ARG GLN GLN ALA GLY LEU GLY ILE LYS LYS SEQRES 12 A 259 LEU ALA GLU SER MET THR LYS VAL ASN GLY VAL ALA ARG SEQRES 13 A 259 VAL GLU LYS ASP GLU ALA LEU PHE LEU LEU ILE VAL VAL SEQRES 14 A 259 GLN MET VAL GLY GLU ALA ALA ARG PHE LYS TYR ILE GLU SEQRES 15 A 259 ASN LEU VAL LEU ASN ASN PHE ASP THR ALA LYS GLU VAL SEQRES 16 A 259 GLU PRO VAL PRO ASP ARG VAL ILE ILE LEU GLU ASN ASN SEQRES 17 A 259 TRP GLY LEU LEU SER ARG ALA ALA LYS THR ALA ASN ASN SEQRES 18 A 259 GLY VAL PHE GLN THR PRO LEU VAL LEU THR SER TYR ALA SEQRES 19 A 259 VAL PRO GLY VAL GLU TRP ARG VAL THR THR VAL ALA GLU SEQRES 20 A 259 VAL GLU ILE GLY ILE PHE LEU ASN VAL ASP ASN ASN SEQRES 1 B 259 VAL ILE ILE TYR GLU LEU ASN LEU GLN GLY THR THR LYS SEQRES 2 B 259 ALA GLN TYR SER THR PHE LEU LYS GLN LEU ARG ASP ASP SEQRES 3 B 259 ILE LYS ASP PRO ASN LEU HIS TYR GLY GLY THR ASN LEU SEQRES 4 B 259 PRO VAL ILE LYS ARG PRO VAL GLY PRO PRO LYS PHE LEU SEQRES 5 B 259 ARG VAL ASN LEU LYS ALA SER THR GLY THR VAL SER LEU SEQRES 6 B 259 ALA VAL GLN ARG SER ASN LEU TYR VAL ALA ALA TYR LEU SEQRES 7 B 259 ALA LYS ASN ASN ASN LYS GLN PHE ARG ALA TYR TYR PHE SEQRES 8 B 259 LYS GLY PHE GLN ILE THR THR ASN GLN LEU ASN ASN LEU SEQRES 9 B 259 PHE PRO GLU ALA THR GLY VAL SER ASN GLN GLN GLU LEU SEQRES 10 B 259 GLY TYR GLY GLU SER TYR PRO GLN ILE GLN ASN ALA ALA SEQRES 11 B 259 GLY VAL THR ARG GLN GLN ALA GLY LEU GLY ILE LYS LYS SEQRES 12 B 259 LEU ALA GLU SER MET THR LYS VAL ASN GLY VAL ALA ARG SEQRES 13 B 259 VAL GLU LYS ASP GLU ALA LEU PHE LEU LEU ILE VAL VAL SEQRES 14 B 259 GLN MET VAL GLY GLU ALA ALA ARG PHE LYS TYR ILE GLU SEQRES 15 B 259 ASN LEU VAL LEU ASN ASN PHE ASP THR ALA LYS GLU VAL SEQRES 16 B 259 GLU PRO VAL PRO ASP ARG VAL ILE ILE LEU GLU ASN ASN SEQRES 17 B 259 TRP GLY LEU LEU SER ARG ALA ALA LYS THR ALA ASN ASN SEQRES 18 B 259 GLY VAL PHE GLN THR PRO LEU VAL LEU THR SER TYR ALA SEQRES 19 B 259 VAL PRO GLY VAL GLU TRP ARG VAL THR THR VAL ALA GLU SEQRES 20 B 259 VAL GLU ILE GLY ILE PHE LEU ASN VAL ASP ASN ASN HET DYN A 260 60 HET DYN B 260 60 HETNAM DYN 5'-O-[(S)-{[(3R,4R)-1-[(4-AMINO-5H-PYRROLO[3,2- HETNAM 2 DYN D]PYRIMIDIN-7-YL)METHYL]-4-({[(S)-HYDROXY(3- HETNAM 3 DYN HYDROXYPROPOXY)PHOSPHORYL]OXY}METHYL)PYRROLIDIN-3- HETNAM 4 DYN YL]OXY}(HYDROXY)PHOSPHORYL]-3'-O-[(R)-HYDROXY(4- HETNAM 5 DYN HYDROXYBUTOXY)PHOSPHORYL]-2'-O-METHYLGUANOSINE FORMUL 3 DYN 2(C30 H47 N10 O17 P3) FORMUL 5 HOH *327(H2 O) HELIX 1 1 THR A 12 LYS A 28 1 17 HELIX 2 2 THR A 97 PHE A 105 1 9 HELIX 3 3 PRO A 106 THR A 109 5 4 HELIX 4 4 GLY A 110 SER A 112 5 3 HELIX 5 5 SER A 122 GLY A 131 1 10 HELIX 6 6 THR A 133 GLY A 138 1 6 HELIX 7 7 GLY A 140 THR A 149 1 10 HELIX 8 8 VAL A 157 VAL A 172 1 16 HELIX 9 9 VAL A 172 PHE A 178 1 7 HELIX 10 10 PHE A 178 ASN A 188 1 11 HELIX 11 11 PRO A 199 ASN A 207 1 9 HELIX 12 12 ASN A 208 THR A 218 1 11 HELIX 13 13 ALA A 246 GLU A 249 5 4 HELIX 14 14 THR B 12 LYS B 28 1 17 HELIX 15 15 THR B 97 PHE B 105 1 9 HELIX 16 16 PRO B 106 THR B 109 5 4 HELIX 17 17 GLY B 110 SER B 112 5 3 HELIX 18 18 SER B 122 GLY B 131 1 10 HELIX 19 19 THR B 133 GLY B 138 1 6 HELIX 20 20 GLY B 140 THR B 149 1 10 HELIX 21 21 VAL B 157 PHE B 178 1 22 HELIX 22 22 PHE B 178 ASN B 188 1 11 HELIX 23 23 PRO B 199 ASN B 207 1 9 HELIX 24 24 ASN B 208 THR B 218 1 11 HELIX 25 25 ALA B 246 GLU B 249 5 4 SHEET 1 A 6 ILE A 3 ASN A 7 0 SHEET 2 A 6 PHE A 51 LYS A 57 1 O ASN A 55 N TYR A 4 SHEET 3 A 6 THR A 62 GLN A 68 -1 O VAL A 63 N LEU A 56 SHEET 4 A 6 VAL A 74 LYS A 80 -1 O ALA A 75 N ALA A 66 SHEET 5 A 6 PHE A 86 TYR A 90 -1 O TYR A 89 N TYR A 77 SHEET 6 A 6 GLN A 114 GLU A 116 1 O GLN A 115 N ALA A 88 SHEET 1 B 2 VAL A 223 LEU A 230 0 SHEET 2 B 2 TRP A 240 THR A 244 -1 O VAL A 242 N LEU A 228 SHEET 1 C 6 ILE B 3 ASN B 7 0 SHEET 2 C 6 PHE B 51 ALA B 58 1 O ASN B 55 N LEU B 6 SHEET 3 C 6 GLY B 61 GLN B 68 -1 O VAL B 67 N LEU B 52 SHEET 4 C 6 VAL B 74 LYS B 80 -1 O LEU B 78 N SER B 64 SHEET 5 C 6 PHE B 86 TYR B 90 -1 O TYR B 89 N TYR B 77 SHEET 6 C 6 GLN B 114 GLU B 116 1 O GLN B 115 N ALA B 88 SHEET 1 D 2 VAL B 223 LEU B 230 0 SHEET 2 D 2 TRP B 240 THR B 244 -1 O VAL B 242 N LEU B 228 CISPEP 1 ARG A 44 PRO A 45 0 -3.44 CISPEP 2 GLY A 47 PRO A 48 0 2.98 CISPEP 3 PRO A 48 PRO A 49 0 0.07 CISPEP 4 GLU A 196 PRO A 197 0 -6.64 CISPEP 5 ARG B 44 PRO B 45 0 0.26 CISPEP 6 GLY B 47 PRO B 48 0 3.49 CISPEP 7 PRO B 48 PRO B 49 0 0.96 CISPEP 8 GLU B 196 PRO B 197 0 -5.89 SITE 1 AC1 20 ASN A 71 LEU A 72 TYR A 73 VAL A 74 SITE 2 AC1 20 GLU A 121 TYR A 123 VAL A 169 GLU A 174 SITE 3 AC1 20 ARG A 177 GLU A 206 ASN A 207 TRP A 209 SITE 4 AC1 20 GLY A 210 ARG A 214 TYR A 233 LEU A 254 SITE 5 AC1 20 HOH A 334 HOH A 336 HOH A 374 HOH A 429 SITE 1 AC2 22 ASN B 71 LEU B 72 TYR B 73 VAL B 74 SITE 2 AC2 22 PHE B 94 GLU B 121 SER B 122 TYR B 123 SITE 3 AC2 22 GLU B 174 ARG B 177 GLU B 206 ASN B 207 SITE 4 AC2 22 ASN B 208 TRP B 209 GLY B 210 ARG B 214 SITE 5 AC2 22 TYR B 233 LEU B 254 HOH B 317 HOH B 337 SITE 6 AC2 22 HOH B 338 HOH B 348 CRYST1 50.716 53.069 54.491 78.65 65.85 80.83 P 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.019718 -0.003183 -0.008467 0.00000 SCALE2 0.000000 0.019087 -0.002819 0.00000 SCALE3 0.000000 0.000000 0.020330 0.00000